Merck opens S$20M lab in Singapore
German biopharmaceutical company Merck has officially opened a S$20 million lab near Pasir Panjang, Singapore. The Merck Singapore Lab offers services such as cell culture media development, purification process optimisation and biologics drug safety testing.
The 3,800 sq m facility will also house Merck’s first BioReliance laboratory in the region, to provide pharmaceutical firms in Asia with quicker, more accessible testing services for biological drug products. The new lab offers consumers the assurance of more speedily available and validated next-generation drugs for treatment. Time taken to validate critical processes, test and release a drug to market will be significantly reduced. According to Dr Koh Poh Koon, Senior Minister of State for Trade and Industry, Merck’s investment in Singapore is timely as global and regional healthcare demands continue to grow. The Government has invested in infrastructure, technology and talent to help propel the industry’s growth and will continue to do so.